Susquehanna Portfolio Strategies’s Cymabay Therapeutics CBAY Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-58,123	Closed	-$1.37M	–	991
2023 Q4	$1.37M	Buy	+58,123	New	+$1.04M	0.02%	524

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna Portfolio Strategies's CBAY Position: Q1 2024 in Review

Susquehanna Portfolio Strategies sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 58,123 shares — an estimated $1.37M sold.

Susquehanna Portfolio Strategies first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $1.37M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Susquehanna Portfolio Strategies reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Susquehanna Portfolio Strategies sold 58,123 Cymabay Therapeutics shares in Q1 2024, an estimated $1.37M.
Susquehanna Portfolio Strategies first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Susquehanna Portfolio Strategies's Cymabay Therapeutics position peaked at $1.37M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2024, filed 7 May 2024.